Distinguishing between bioactive and modeled compound conformations through mining of emerging chemical patterns.

J Chem Inf Model

Department of Life Science informatics, B-IT, LIMES Program Unit Chemical Biology & Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstrasse 2, D-53113 Bonn, Germany.

Published: September 2008

To systematically compare bioactive and theoretically derived compound conformations, we have analyzed 18 different sets of active small molecules with experimentally determined binding conformations and modeled conformers using a pattern recognition approach. Compound class-specific descriptor value range patterns that accurately distinguish bioactive conformations from other low-energy conformers were identified for all 18 compound classes. Discriminatory patterns were often chemically intuitive and could be well rationalized on the basis of X-ray structures of the protein-ligand complexes. Target-specific descriptor patterns can be used as filters to screen conformational ensembles for bioactive conformations.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ci8001793DOI Listing

Publication Analysis

Top Keywords

compound conformations
8
bioactive conformations
8
conformations
5
distinguishing bioactive
4
bioactive modeled
4
compound
4
modeled compound
4
conformations mining
4
mining emerging
4
emerging chemical
4

Similar Publications

In silico drug repurposing at the cytoplasmic surface of human aquaporin 1.

PLoS One

January 2025

Genome and Structural Bioinformatics Group, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, United Kingdom.

Aquaporin 1 (AQP1) is a key channel for water transport in peritoneal dialysis. Inhibition of AQP1 could therefore impair water transport during peritoneal dialysis. It is not known whether inhibition of AQP1 occurs unintentionally due to off-target interactions of administered medications.

View Article and Find Full Text PDF

Our recently developed approach based on the local coupled-cluster with single, double, and perturbative triple excitation [LCCSD(T)] model gives very efficient means to compute the ideal-gas enthalpies of formation. The expanded uncertainty (95% confidence) of the method is about 3 kJ·mol for medium-sized compounds, comparable to typical experimental measurements. Larger compounds of interest often exhibit many conformations that can significantly differ in intramolecular interactions.

View Article and Find Full Text PDF

Chronic lymphocytic leukemia (CLL) is a malignancy caused by the overexpression of the anti-apoptotic protein B-cell lymphoma-2 (BCL-2), making it a critical therapeutic target. This study integrates computational screening, molecular docking, and molecular dynamics to identify and validate novel BCL-2 inhibitors from the ChEMBL database. Starting with 836 BCL-2 inhibitors, we performed ADME and Lipinski's Rule of Five (RO5) filtering, clustering, maximum common substructure (MCS) analysis, and machine learning models (Random Forest, SVM, and ANN), yielding a refined set of 124 compounds.

View Article and Find Full Text PDF

Background: We identified small molecule tricyclic pyrone compound CP2 as a mild mitochondrial complex I (MCI) inhibitor that induces neuroprotection in multiple mouse models of AD. One of the major concerns while targeting mitochondria is the production of reactive oxygen species (ROS). CP2 consists of two diastereoisomers, D1 and D2, with distinct activity and toxicity profiles.

View Article and Find Full Text PDF

Background: Neurological disorders are at epidemic levels in the world today. Various proteins are being targeted for the development of novel molecular therapeutics; however, no small-molecule inhibitors have been discovered. Recent studies suggest that there are few molecules in clinical trials for various secretase (α, β, and γ), caspase, and calpain inhibitors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!